Hilary Petersmeyer Bagshaw, MD
Radiation Oncology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
- Since medical school
- 15 years
- Temple University School of Medicine, 2011
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Adventist Health Mendocino Coast · Community Hospital of the Monterey Peninsula · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bagshaw’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A133849 · Current
Licensed to practise in California · since 2014 · expires 2028-09-30 · Temple University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Radiology - Radiation Oncology
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health Mendocino CoastFort Bragg, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 5 of 5 · 80% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Community Hospital of the Monterey PeninsulaMonterey, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Montage HealthPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.48 (1.22 to 1.74), Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 3.12 (1.69 to 4.56) · 1,095 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 19.24 (14.17 to 24.3) · 1,118 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative sepsis rate: 9.62 (6.42 to 12.82) · 1,086 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.39, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Mendocino Coast
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for heart failure patientsComplications and deaths | 9 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 103 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 268 cases | None | Jul 2024 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 78 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -24.2 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.7 · 102 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 101 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.7 (5.2 to 11.1) · 65 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7.3 to 14.6) · 65 cases | No different | Jan 2024 – Dec 2024 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.8 to 17.4) · 526 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 48 cases | No different | Jan 2024 – Dec 2024 |
What patients said (119 patients answered, 22% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 5 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 86% |
| Nurses "always" communicated well | 86% |
| Doctors "always" communicated well | 89% |
| Staff "always" explained | 72% |
| Yes, staff "did" give patients this information | 94% |
| Yes, staff "did" give patients information about help after discharge | 94% |
| Doctors "always" explained things so they could understand | 85% |
| Doctors "always" listened carefully | 87% |
| Doctors "always" treated them with courtesy and respect | 96% |
| Patients who gave a rating of "9" or "10" (high) | 86% |
| Staff "always" explained new medications | 87% |
| Nurses "always" explained things so they could understand | 82% |
| Nurses "always" listened carefully | 84% |
| Nurses "always" treated them with courtesy and respect | 92% |
| "Always" quiet at night | 56% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Community Hospital of the Monterey Peninsula
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.48 (1.22 to 1.74) | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.12 (1.69 to 4.56) · 1,095 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 19.24 (14.17 to 24.3) · 1,118 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 9.62 (6.42 to 12.82) · 1,086 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.39 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.39 to 2.16) · 1,873 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.2 (110.65 to 205.75) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.7 · 686 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 1,072 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 3,300 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.11 to 0.48) · 10,234 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.46) · 10,572 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.25 (1.47 to 5.04) · 2,617 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.37 (1.04 to 3.7) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.21 (0.75 to 3.66) · 744 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0.06 to 1.17) · 8,715 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.2 · 156 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.28 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.799 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.732 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 152 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 625 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 6.3 · 193 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.2 · 749 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7 · 1,074 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 850 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4 (2.7 to 5.8) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (10.4 to 17.4) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 153 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.9 to 18.6) · 711 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 746 cases | No different | Jan 2024 – Dec 2024 |
What patients said (520 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 5 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$234,758
Medicare paid this office $234,758 for 364 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| High precision radiation therapy planning | 59 | $26,234 | $386 |
| Radiation treatment management, 5 treatment sessions | 41 | $24,187 | $177 |
| Insertion of needle or tube into prostate for radiation therapy | 27 | $23,590 | $715 |
| Ct guidance for insertion of radiation therapy fields | 41 | $18,744 | $40 |
| Management of cranial lesion surgery using radiation over multiple sessions | 26 | $15,835 | $586 |
See all 27 services
| High precision radiation therapy planning | 59 | $26,234 | $386 |
| Radiation treatment management, 5 treatment sessions | 41 | $24,187 | $177 |
| Insertion of needle or tube into prostate for radiation therapy | 27 | $23,590 | $715 |
| Ct guidance for insertion of radiation therapy fields | 41 | $18,744 | $40 |
| Management of cranial lesion surgery using radiation over multiple sessions | 26 | $15,835 | $586 |
| Complex radiation therapy planning | 88 | $14,515 | $153 |
| Design and construction of radiation treatment device for high precision radiation therapy | 60 | $14,435 | $206 |
| Calculation of radiation therapy dose | 70 | $14,146 | $30 |
| Short return visit (20+ min) | 126 | $12,203 | $80 |
| New patient visit (60+ min) | 72 | $11,657 | $162 |
| 3d radiation therapy planning | 39 | $9,991 | $208 |
| High dose radiation therapy, more than 12 channels | 24 | $7,810 | $260 |
| New patient visit (60+ min) | 43 | $7,377 | $172 |
| Design and construction of complex radiation treatment device | 21 | $4,418 | $56 |
| Long return visit (40+ min) | 22 | $3,969 | $173 |
| Special radiation treatment | 35 | $3,652 | $99 |
| Short return visit (20+ min) | 54 | $3,151 | $50 |
| Return visit (30+ min) | 17 | $1,941 | $114 |
| Ultrasonic guidance for administration of radiation therapy | 25 | $1,914 | $62 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 14 | $1,218 | $76 |
| Return visit (30+ min) | 14 | $1,049 | $75 |
| Placement of device in prostate for radiation therapy | 16 | $750 | $47 |
| New patient visit (30+ min) | 11 | $711 | $65 |
| Design and construction of simple radiation treatment device | 27 | $684 | $22 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 37 | $553 | $15 |
| Short return visit | 13 | $483 | $37 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 19 | $284 | $15 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Insertion of needle or tube into prostate for radiation therapy | 32 | 21 | 27 | – | 19 | 33 |
| Placement of device in prostate for radiation therapy | – | – | – | – | – | 16 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
364 Original Medicare patients in 2024. Average age 76 · Women 4% · Also on Medicaid 9% · Health risk score 1.39. At or below the middle of the specialty; the typical radiation oncology clinician is at 1.69.
Conditions among them: Cancer 75% · High blood pressure 64% · Coronary heart disease 32% · Diabetes 21% · Chronic kidney disease 20% · Atrial fibrillation 15% · Heart failure 10% · Depression 9% · COPD 7% · Stroke 7% · Dementia 4%.
The office billed $2,775,033, Medicare allowed $300,957 and paid $234,758; for 2,181 services of 37 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 364 | 2,181 | 76 | 1.39 | $2,775,033 | $234,758 |
| 2023 | 302 | 1,760 | 74 | 1.29 | $2,062,080 | $178,174 |
| 2022 | 229 | 1,044 | 74 | 1.42 | $1,130,075 | $112,110 |
| 2021 | 231 | 1,243 | 74 | 1.37 | $1,378,984 | $145,082 |
| 2020 | 249 | 1,392 | 73 | 1.67 | $1,518,995 | $215,380 |
| 2019 | 258 | 1,746 | 73 | 1.58 | $1,602,399 | $282,955 |
| 2018 | 201 | 1,592 | 73 | 1.79 | $1,389,322 | $270,034 |
| 2017 | 198 | 1,248 | 74 | 1.41 | $851,844 | $139,464 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 21 services
| Radiation treatment management, 5 treatment sessions | 40 | $20,326 | $178 |
| High precision radiation therapy planning | 34 | $17,666 | $393 |
| Ct guidance for insertion of radiation therapy fields | 44 | $16,225 | $42 |
| New patient visit (60+ min) | 101 | $14,982 | $148 |
| Insertion of needle or tube into prostate for radiation therapy | 14 | $12,854 | $677 |
| Calculation of radiation therapy dose | 44 | $10,860 | $31 |
| 3d radiation therapy planning | 30 | $10,319 | $211 |
| Management of cranial lesion surgery using radiation over multiple sessions | 16 | $10,073 | $593 |
| Design and construction of radiation treatment device for high precision radiation therapy | 34 | $9,477 | $211 |
| Complex radiation therapy planning | 57 | $9,012 | $155 |
| Short return visit (20+ min) | 135 | $8,705 | $50 |
| High dose radiation therapy, more than 12 channels | 14 | $5,043 | $252 |
| Design and construction of complex radiation treatment device | 21 | $3,488 | $56 |
| Return visit (30+ min) | 32 | $3,177 | $84 |
| Long return visit (40+ min) | 24 | $2,801 | $108 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 17 | $2,078 | $74 |
| Special radiation treatment | 17 | $1,793 | $100 |
| Ultrasonic guidance for administration of radiation therapy | 13 | $1,178 | $62 |
| New patient visit (30+ min) | 12 | $888 | $74 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 16 | $820 | $19 |
| Design and construction of simple radiation treatment device | 14 | $402 | $22 |
2022: 14 services
| Radiation treatment management, 5 treatment sessions | 39 | $15,647 | $178 |
| High precision radiation therapy planning | 30 | $11,771 | $392 |
| Ct guidance for insertion of radiation therapy fields | 39 | $11,527 | $41 |
| New patient visit (60+ min) | 63 | $9,723 | $154 |
| Management of cranial lesion surgery using radiation over multiple sessions | 13 | $7,694 | $592 |
| Design and construction of radiation treatment device for high precision radiation therapy | 31 | $7,162 | $211 |
| Complex radiation therapy planning | 40 | $6,205 | $155 |
| Return visit (30+ min) | 59 | $4,659 | $67 |
| 3d radiation therapy planning | 15 | $3,991 | $210 |
| Short return visit (20+ min) | 61 | $3,545 | $51 |
| Calculation of radiation therapy dose | 36 | $3,533 | $30 |
| Long return visit (40+ min) | 24 | $3,060 | $118 |
| Special radiation treatment | 14 | $1,399 | $100 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 13 | $526 | $12 |
2021: 17 services
| Insertion of needle or tube into prostate for radiation therapy | 20 | $19,750 | $731 |
| Radiation treatment management, 5 treatment sessions | 32 | $15,880 | $180 |
| New patient visit (60+ min) | 81 | $12,948 | $160 |
| High precision radiation therapy planning | 23 | $10,793 | $400 |
| Ct guidance for insertion of radiation therapy fields | 36 | $10,260 | $43 |
| 3d radiation therapy planning | 25 | $8,575 | $214 |
| Return visit (30+ min) | 70 | $8,196 | $84 |
| Complex radiation therapy planning | 45 | $7,611 | $159 |
| High dose radiation therapy, more than 12 channels | 21 | $7,493 | $268 |
| Design and construction of radiation treatment device for high precision radiation therapy | 24 | $6,431 | $214 |
| Long return visit (40+ min) | 33 | $4,633 | $125 |
| Calculation of radiation therapy dose | 29 | $3,515 | $31 |
| Short return visit (20+ min) | 56 | $3,375 | $46 |
| Special radiation treatment | 31 | $3,164 | $102 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 23 | $1,841 | $20 |
| Ultrasonic guidance for administration of radiation therapy | 21 | $1,785 | $64 |
| Design and construction of simple radiation treatment device | 21 | $568 | $23 |
2020: 29 services
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 34 | $48,498 | $391 |
| Insertion of needle or tube into prostate for radiation therapy | 13 | $15,274 | $727 |
| Radiation treatment management, 5 treatment sessions | 19 | $11,060 | $181 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 17 | $9,524 | $280 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 46 | $8,951 | $78 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 11 | $7,012 | $280 |
| Radiation treatment management, 5 treatment sessions | 13 | $6,909 | $177 |
| 3d radiation therapy planning | 23 | $6,731 | $217 |
| Ct guidance for insertion of radiation therapy fields | 17 | $6,115 | $125 |
| Ct guidance for insertion of radiation therapy fields | 22 | $6,050 | $43 |
| High dose radiation therapy, more than 12 channels | 13 | $5,701 | $271 |
| High precision radiation therapy planning | 11 | $4,741 | $395 |
| Complex radiation therapy planning | 25 | $4,329 | $160 |
| Continuing radiation therapy consultation per week | 19 | $3,470 | $85 |
| Calculation of radiation therapy dose | 19 | $3,297 | $29 |
| Short return visit (20+ min) | 61 | $3,182 | $42 |
| New patient visit (60+ min) | 22 | $3,102 | $141 |
| Short return visit (20+ min) | 49 | $2,937 | $54 |
| Design and construction of radiation treatment device for high precision radiation therapy | 11 | $2,814 | $216 |
| Special radiation treatment | 19 | $2,066 | $98 |
| New patient visit (45+ min) | 15 | $2,041 | $136 |
| Complex radiation therapy planning | 12 | $1,879 | $157 |
| Calculation of radiation therapy dose | 11 | $1,876 | $67 |
| Design and construction of complex radiation treatment device | 13 | $1,809 | $58 |
| Ultrasonic guidance for administration of radiation therapy | 13 | $1,218 | $64 |
| Return visit (30+ min) | 17 | $1,179 | $66 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 23 | $1,134 | $19 |
| Long return visit (40+ min) | 11 | $1,112 | $101 |
| Design and construction of simple radiation treatment device | 13 | $480 | $23 |
2019: 34 services
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 45 | $60,984 | $381 |
| Insertion of needle or tube into prostate for radiation therapy | 19 | $22,953 | $717 |
| High precision radiation therapy planning | 11 | $22,210 | $2,019 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 25 | $14,363 | $282 |
| Radiation treatment management, 5 treatment sessions | 25 | $12,328 | $174 |
| Radiation treatment management, 5 treatment sessions | 24 | $11,417 | $176 |
| Ct guidance for insertion of radiation therapy fields | 20 | $10,995 | $122 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 60 | $9,451 | $78 |
| 3d radiation therapy planning | 24 | $7,986 | $210 |
| High dose radiation therapy, more than 12 channels | 18 | $7,650 | $264 |
| High precision radiation therapy planning | 18 | $6,986 | $388 |
| Complex radiation therapy planning | 42 | $6,966 | $155 |
| Design and construction of radiation treatment device for high precision radiation therapy | 12 | $6,513 | $501 |
| Ct guidance for insertion of radiation therapy fields | 31 | $6,488 | $42 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 14 | $6,469 | $281 |
| New patient visit (60+ min) | 39 | $5,928 | $152 |
| Continuing radiation therapy consultation per week | 32 | $3,794 | $84 |
| Design and construction of radiation treatment device for high precision radiation therapy | 17 | $3,573 | $210 |
| Calculation of radiation therapy dose | 25 | $3,472 | $30 |
| Calculation of radiation therapy dose | 19 | $3,250 | $66 |
| Special radiation treatment | 29 | $2,981 | $99 |
| Complex radiation therapy planning | 17 | $2,717 | $151 |
| New patient visit (45+ min) | 17 | $2,602 | $153 |
| Short return visit (20+ min) | 23 | $2,427 | $69 |
| Return visit (30+ min) | 25 | $2,368 | $72 |
| Short return visit (20+ min) | 35 | $2,356 | $41 |
| New patient visit (60+ min) | 12 | $2,266 | $189 |
| Return visit (30+ min) | 18 | $2,264 | $103 |
| Design and construction of complex radiation treatment device | 16 | $2,033 | $56 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 37 | $1,990 | $19 |
| Ultrasonic guidance for administration of radiation therapy | 18 | $1,945 | $63 |
| Long return visit (40+ min) | 15 | $1,641 | $97 |
| Design and construction of simple radiation treatment device | 19 | $715 | $22 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 11 | $384 | $35 |
2018: 29 services
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 36 | $66,859 | $371 |
| High precision radiation therapy planning | 11 | $22,451 | $2,041 |
| Insertion of needle or tube into prostate for radiation therapy | 18 | $22,361 | $699 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 19 | $15,096 | $285 |
| Radiation treatment management, 5 treatment sessions | 36 | $13,664 | $169 |
| Ct guidance for insertion of radiation therapy fields | 28 | $11,388 | $120 |
| 3d radiation therapy planning | 30 | $9,915 | $202 |
| Radiation treatment management, 5 treatment sessions | 25 | $9,020 | $170 |
| High dose radiation therapy, more than 12 channels | 18 | $8,224 | $257 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 41 | $7,507 | $77 |
| Complex radiation therapy planning | 32 | $5,087 | $145 |
| Calculation of radiation therapy dose | 21 | $4,278 | $28 |
| Continuing radiation therapy consultation per week | 31 | $4,127 | $84 |
| Ct guidance for insertion of radiation therapy fields | 24 | $4,096 | $41 |
| New patient visit (45+ min) | 33 | $3,663 | $111 |
| Design and construction of complex radiation treatment device | 12 | $3,594 | $128 |
| Calculation of radiation therapy dose | 14 | $3,169 | $66 |
| Special radiation treatment | 29 | $2,971 | $93 |
| New patient visit (45+ min) | 19 | $2,807 | $148 |
| Design and construction of complex radiation treatment device | 13 | $2,504 | $54 |
| Short return visit (20+ min) | 31 | $2,287 | $41 |
| New patient visit (60+ min) | 14 | $2,107 | $151 |
| Ultrasonic guidance for administration of radiation therapy | 18 | $1,976 | $62 |
| Complex radiation therapy planning | 12 | $1,940 | $149 |
| Long return visit (40+ min) | 13 | $1,297 | $100 |
| Return visit (30+ min) | 15 | $1,100 | $61 |
| Design and construction of simple radiation treatment device | 18 | $660 | $22 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 16 | $596 | $19 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 13 | $427 | $30 |
2017: 20 services
| Insertion of needle or tube into prostate for radiation therapy | 14 | $17,492 | $700 |
| Radiation treatment management, 5 treatment sessions | 45 | $15,543 | $167 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 11 | $9,905 | $354 |
| 3d radiation therapy planning | 37 | $9,475 | $202 |
| Complex radiation therapy planning | 48 | $7,130 | $149 |
| Calculation of radiation therapy dose | 39 | $6,767 | $30 |
| Ct guidance for insertion of radiation therapy fields | 38 | $6,618 | $40 |
| High precision radiation therapy planning | 15 | $6,413 | $377 |
| High dose radiation therapy, more than 12 channels | 14 | $6,102 | $254 |
| New patient visit (45+ min) | 47 | $5,429 | $116 |
| Design and construction of radiation treatment device for high precision radiation therapy | 15 | $3,844 | $202 |
| Design and construction of complex radiation treatment device | 30 | $3,749 | $54 |
| Special radiation treatment | 38 | $3,653 | $96 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 31 | $1,879 | $19 |
| Short return visit (20+ min) | 33 | $1,764 | $43 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 19 | $1,479 | $74 |
| Ultrasonic guidance for administration of radiation therapy | 14 | $1,462 | $61 |
| Return visit (30+ min) | 16 | $1,199 | $71 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 23 | $828 | $33 |
| Design and construction of simple radiation treatment device | 14 | $540 | $22 |
Drugs they prescribed that Part D paid
$35,979
Pharmacies billed $35,979 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
196 generic and 16 brand-name prescriptions · $35,979 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Orgovyx | 12 | $31,748 | $2,646 |
| Tamsulosin | 110 | $1,639 | $15 |
| Famotidine | 39 | $239 | $6 |
| Dexamethasone | 11 | $161 | $15 |
Year by year
| 2024 | 212 | 63 | None | 8% | $35,979 |
| 2023 | 87 | 30 | 0% (0) | None | $14,718 |
| 2022 | 74 | 25 | 0% (0) | None | $2,058 |
| 2021 | 81 | 32 | 0% (0) | None | $2,184 |
| 2020 | 46 | 23 | None | 0% | $1,077 |
| 2019 | 131 | 45 | 15% (20) | None | $5,216 |
| 2018 | 175 | 44 | None | None | $5,251 |
| 2017 | 128 | 43 | None | None | $3,567 |
| 2015 | 21 | None | None | None | $820 |
| 2014 | 11 | None | None | 0% | $253 |
| 2013 | 42 | 20 | 33% (14) | None | $1,086 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Tamsulosin | 34 | $779 | $23 |
| Famotidine | 16 | $259 | $16 |
2022: 1 drug
| Tamsulosin | 45 | $892 | $20 |
2021: 1 drug
| Tamsulosin | 52 | $1,189 | $23 |
2020: 1 drug
| Tamsulosin | 24 | $382 | $16 |
2019: 2 drugs
| Tamsulosin | 67 | $1,607 | $24 |
| Famotidine | 18 | $160 | $9 |
2018: 4 drugs
| Tamsulosin | 82 | $2,388 | $29 |
| Famotidine | 29 | $397 | $14 |
| Dexamethasone | 11 | $112 | $10 |
| Ciprofloxacin | 14 | $112 | $8 |
2017: 4 drugs
| Tamsulosin | 52 | $1,526 | $29 |
| Bicalutamide | 12 | $121 | $10 |
| Famotidine | 16 | $109 | $7 |
| Ciprofloxacin | 13 | $103 | $8 |
Money from drug and device companies
$213 in 2024
| 2024 | 1 | 1 | None | $213 |
| 2023 | 1 | 2 | None | $164 |
| 2022 | 1 | 1 | None | $29 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sumitomo Pharma America | Orgovyx | $213 | 1 payment
|
See the published payment
| Sumitomo Pharma America | Meals · 2024-06-07 | Orgovyx | $213 |
See earlier years (2023, 2022)
2023: $164
| Astellas Pharma US | None | $164 | 2 payments
|
2022: $29
| Palette Life Sciences | None | $29 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Novartis Pharmaceuticals Corporation · An International Prospective Open-Label, Multi-Center, Randomized Phase III Study Comparing [177lu] Lu-Psma-617 Versus Observation To Delay Castration Or Disease Recurrence in Adult Male Patients With Psma Positive Oligometastatic Prostate Cancer (Ompc) · 2025 | Their institution | $25,683 |
| Novartis Pharmaceuticals Corporation · An International Prospective Open-Label, Multi-Center, Randomized Phase III Study Comparing [177lu] Lu-Psma-617 Versus Observation To Delay Castration Or Disease Recurrence in Adult Male Patients With Psma Positive Oligometastatic Prostate Cancer (Ompc) · 2024 | Their institution | $194 |
Professional record
- NPI
- 1487943916
- Licence
- CA A133849California A133849: Current · expires 2028-09-30
- Trained
- Temple University School of Medicine, 2011 · 15 years ago
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2085R0001X (2085R0001X); Student in a training program (390200000X)
- Mailing address
- 875 Blake Wilbur Dr, Palo Alto, CA, 94304
- NPI first listed
- 2011-04-05
- NPI last updated
- 2019-05-01
This is when the NPI record was last certified, not a medical board exam.